Pharmaceutical

emerging-chronic-pruritus-drugs

Articles

4 Investigational Chronic Pruritus Drugs Shaping the Treatment Landscape

Explore More...
pharma-news-for-roche-astrazeneca-replimune

FDA Approves Genentech’s GAZYVA for Lupus Nephritis; Glaukos’ EPIOXA Wins FDA Approval for Keratoconus Treatment; FDA Accepts Replimune’s RP1 BLA Resubmission for Advanced Melanoma; Cogent’s Bezuclastinib Earns FDA Breakthrough Therapy for SM-AHN; Amgen’s TEZSPIRE Gets FDA Nod for Chronic Rhinosinusitis with Nasal Polyps

peanut-allergy-treatment-landscape

Peanut Allergy Treatment Space: Expanding Horizons Beyond Traditional Immunotherapy

tukysa-positive-phase-iii-results

Seagen’s TUKYSA Powers Pfizer’s Next HER2-Positive Breast Cancer Milestone

5-schizophrenia-drugs-challenging-bms-karxt

5 Upcoming Schizophrenia Drugs Competitors for Newly Approved BMS’ KarXT (COBENFY)

pharma-news-for-boehringer-denali-regeneron

FDA Approves Boehringer’s JASCAYD as First New IPF Therapy in Over a Decade; Denali Therapeutics’ Tividenofusp Alfa BLA Review for Hunter Syndrome Extended by FDA; Bicara’s Ficerafusp Alfa Earns FDA Breakthrough Tag for 1L HPV-Negative Head & Neck Cancer; BeOne Medicines’ Sonrotoclax Granted FDA Breakthrough Designation for Cancer Treatment; FDA Clears LIBTAYO for Adjuvant Use in Cutaneous Squamous Cell Carcinoma

chronic-pruritus-treatment-landscape

Expanding Horizons in Chronic Pruritus Treatment: Emerging Therapies Target Diverse Mechanisms

jascayd-for-ipf-treatment

Boehringer Ingelheim’s JASCAYD Brings Hope Back to IPF Patients After a Decade of Waiting

dietary-approaches-for-gastroparesis

Gastroparesis Treatment: How Nutrition Can Support Symptom Management?

pharma-news-for-aminex-eccogene-taysha

Aminex Therapeutics Secures FDA Orphan Drug Designation for AMXT 1501 + DFMO in Neuroblastoma; Eccogene Gets FDA Nod to Begin Phase IIa MOSAIC Trial of ECC4703 + ECC0509 in MASH; Orca Bio’s Orca-T Earns FDA Priority Review for Hematologic Malignancies; Alto Neuroscience Gains FDA Fast Track for ALTO-101 in Cognitive Impairment Linked to Schizophrenia; Taysha Gene Therapies Wins FDA Breakthrough Therapy Status for TSHA-102 in Rett Syndrome

traumatic-brain-injury-treatment

Innovative RoA in Traumatic Brain Injury Treatment: Intranasal and Intrathecal Approaches

ovarian-cancer-treatment-landscape

Shaping the Future of Ovarian Cancer Treatment: From PARP Inhibitors to ADCs

herbal-medicine-market-assessment

Botanical Bounty: Cracking the Herbal Medicine Market Enigma and Growth Potential

pharma-news-for-regeneron-kedrion-crinetics

Regeneron’s EVKEEZA Wins FDA Approval for HoFH in Children as Young as 1 Year; Eli Lilly’s INLURIYO Approved for ER+, HER2-, ESR1-Mutated Advanced Breast Cancer; Janssen’s TREMFYA Secures FDA Nod for Pediatric Plaque Psoriasis and Psoriatic Arthritis; Kedrion Biopharma’s QIVIGY Approved for Primary Humoral Immunodeficiency in Adults; Crinetics Pharma Wins FDA Approval for First Daily Pill, PALSONIFY, for Rare Growth Disorder

essential-thrombocythemia-treatment-gap

Essential Thrombocythemia Treatment—Why the US Lags Behind Europe?

anzupgo-cream-for-chronic-hand-eczema

Leo’s ANZUPGO Cream: First FDA-Approved Treatment for Adults with Moderate-to-Severe Chronic Hand Eczema

Endometriosis _ Understanding the complex disease

Endometriosis: The Unseen Burden and the Road Toward Transformative Therapies

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader